Results 231 to 240 of about 182,731 (328)

Geographic and Socioeconomic Landscape of Veterans With Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background US Veterans experience higher rates and worse outcomes for head and neck squamous cell carcinoma (HNSCC) compared to civilians. Geographic and socioeconomic barriers remain unclear. Methods This retrospective descriptive study analyzed VA data nationwide (2012–2022), identifying Veterans with HNSCC using ICD codes. Subsites included
Kristen L. Zayan   +8 more
wiley   +1 more source

Otolaryngology Workforce Projections in the United States, 2021-2036. [PDF]

open access: yesLaryngoscope Investig Otolaryngol
Berisha L   +10 more
europepmc   +1 more source

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella   +12 more
wiley   +1 more source

Vestibular influence on cranio-cervical pain:A case report [PDF]

open access: yes, 2012
Cross, Caroline   +2 more
core  

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon   +6 more
wiley   +1 more source

Pretreatment Neutrophil‐to‐Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Pretreatment neutrophil to lymphocyte ratio (NLR) is a negative prognostic marker for survival in head and neck cancer (HNC). Its association with treatment toxicity and intolerance in patients undergoing curative‐intent surgery is unknown. Methods Ambispective study of patients with operable stage II–IV, HPV‐negative HNC treated at
Raisa Chowdhury   +12 more
wiley   +1 more source

Surgical interventions for the early management of Bell's palsy [PDF]

open access: yes, 2011
Adour   +30 more
core   +2 more sources

Home - About - Disclaimer - Privacy